Skip to main content

Table 3 Performance evaluation for Alzheimer’s disease

From: Mining biomarker information in biomedical literature

Selection Rank Recall Precision F-score
Baseline: Genes / Proteins 60 0.10 0.92 0.17
  230 0.30 0.73 0.42
  469 0.50 0.61 0.55
Maximal F-score 728 0.67 0.52 0.59
Baseline + Clinical Management 61 0.10 0.90 0.17
  226 0.30 0.75 0.42
  465 0.50 0.61 0.55
Maximal F-score 682 0.65 0.54 0.59
Baseline + Evidence Marker 62 0.10 0.89 0.17
  225 0.30 0.75 0.42
  464 0.50 0.61 0.55
Maximal F-score 654 0.62 0.54 0.57
Baseline +Prognosis 63 0.10 0.87 0.17
  247 0.30 0.68 0.41
  541 0.50 0.52 0.51
Maximal F-score 740 0.61 0.47 0.53
Baseline + Diagnostics 64 0.10 0.86 0.17
  237 0.30 0.71 0.42
  494 0.50 0.57 0.53
Maximal F-score 520 0.52 0.57 0.54
Baseline + Statistics 64 0.10 0.86 0.17
  227 0.30 0.74 0.42
  678 0.50 0.42 0.45
Maximal F-score 377 0.41 0.62 0.49
Baseline + Clinical Management + Evidence Marker 60 0.10 0.92 0.17
  224 0.30 0.75 0.42
  451 0.50 0.63 0.56
Maximal F-score 555 0.57 0.59 0.58
Baseline + Clinical Management + Evidence Marker + Prognosis 61 0.10 0.90 0.17
  230 0.30 0.73 0.42
  568 0.50 0.50 0.50
Maximal F-score 479 0.47 0.56 0.51
  1. Genes were ranked based on frequency and evaluated against the Alzheimer’s gold standard. For the different selections recall, precision, F-score and rank has been estimated for 10, 30, and 50% recall. In addition the maximal recall has been estimated.